Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers

Emmanuelle Martinez, Françoise Silvy, Fréderic Fina, Marc Bartoli, Martin Krahn, Fabrice Barlési, Dominique Figarella‐Branger, Juan Iovanna, René Laugier, Mehdi Ouaïssi,

Oncotarget · 2015 · 11 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

// Emmanuelle Martinez 1, 2 , Françoise Silvy 1, 2 , Fréderic Fina 1, 2, 3 , Marc Bartoli 4 , Martin Krahn 4, 5 , Fabrice Barlesi 1, 2, 6 , Dominique Figarella-Branger 1, 2, 7 , Juan Iovanna 8, 9, 10 , René Laugier 11 , Mehdi Ouaissi 1, 2, 12 , Dominique Lombardo 1, 2 , Eric Mas 1, 2 1 Aix-Marseille Université, CRO2, Centre de Recherche en Oncologie biologique et Oncopharmacologie, F-13005, Marseille, France 2 INSERM, UMR_S 911, F-13005, Marseille, France 3 LBM- Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service de Transfert d’Oncologie Biologique, F-13015, Marseille, France 4 Aix-Marseille Université, INSERM, UMR 910, F-13005, Marseille, France 5 Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone-Enfants, Département de Génétique Médicale, F-13005, Marseille, France 6 Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d’Oncologie Multidisciplinaire & Innovation Thérapeutique, F-13915, Marseille, France 7 Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Service d’Anatomopathologie, F-13005, Marseille, France 8 Aix-Marseille Université, CRCM, Centre de Recherche en Cancérologie de Marseille, F-13009, Marseille, France 9 INSERM, UMR_S 1068, F-13009, Marseille, France 10 CNRS, UMR 7258, F-13009, Marseille, France 11 Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Service de Gastroentérologie, F-13005, Marseille, France 12 Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Service de Chirurgie Digestive et Viscérale, F-13005, Marseille, France Correspondence to: Eric Mas, e-mail: eric.mas@univ-amu.fr Dominique Lombardo, e-mail: dominique.lombardo@univ-amu.fr Keywords: SNP, rs488087, pancreatic cancer Abbreviations: BSDL, bile-salt-dependent lipase; PDAC, pancreatic ductal adenocarcinoma; PC, pancreatic cancers Received: June 23, 2015      Accepted: October 05, 2015      Published: October 16, 2015 ABSTRACT Pancreatic cancer (PC) is a devastating disease progressing asymptomatically until death within months after diagnosis. Defining at-risk populations should promote its earlier diagnosis and hence also avoid its development. Considering the known involvement in pancreatic disease of exon 11 of the bile salt-dependent lipase (BSDL) gene that encodes variable number of tandem repeat (VNTR) sequences, we hypothesized upon the existence of a genetic link between predisposition to PC and mutations in VNTR loci. To test this, BSDL VNTR were amplified by touchdown-PCR performed on genomic DNA extracted from cancer tissue or blood samples from a French patient cohort and amplicons were Sanger sequenced. A robust method using probes for droplet digital (dd)-PCR was designed to discriminate the C/C major from C/T or T/T minor genotypes. We report that the c.1719C > T transition (SNP rs488087) present in BSDL VNTR may be a useful marker for defining a population at risk of developing PC (occurrence: 63.90% in the PC versus 27.30% in the control group). The odds ratio of 4.7 for the T allele was larger than those already determined for other SNPs suspected to be predictive of PC. Further studies on tumor pancreatic tissue suggested that a germline T allele may favor Kras G12R/G12D somatic mutations which represent negative prognostic factors associated with reduced survival. We propose that the detection of the T allele in rs488087 SNP should lead to an in-depth follow-up of patients in whom an association with other potential risk factors of pancreatic cancer may be present.

References

40